Mechanisms involved in 3′,5′-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle

Endocrinology

Volumn 150, Issue 12, 2009, Pages 5395-5404

  Gonçalves, Dawit A P ^a   Lira, Eduardo C ^a   Baviera, Amanda M ^b   Cao, Peirang ^c   Zanon, Neusa M ^a   Arany, Zoltan ^c   Bedard, Nathalie ^d   Tanksale, Preeti ^c   Wing, Simon S ^d   Lecker, Stewart H ^c   Kettelhut, Isis C ^a   Navegantes, Luiz Carlos Carvalho ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MATO GROSSO   (Brazil)

^c HARVARD MEDICAL SCHOOL   (United States)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3',5' CYCLIC ADENOSINE MONOPHOSPHATE; ATROGIN 1; BETA 2 ADRENERGIC RECEPTOR; CLENBUTEROL; CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIET RESTRICTION; MALE; MOUSE; MUSCLE ATROPHY; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; STIMULATION;

1-METHYL-3-ISOBUTYLXANTHINE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CLENBUTEROL; CYCLIC AMP; DEXAMETHASONE; FORKHEAD TRANSCRIPTION FACTORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SKELETAL; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKP CULLIN F-BOX PROTEIN LIGASES; TRANS-ACTIVATORS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 71949085738     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0428     Document Type: Article

References (37)

1. Viguerie N, Clement K, Barbe P, Courtine M, Benis A, Larrouy D, Hanczar B, Pelloux V, Poitou C, Khalfallah Y, Barsh GS, Thalamas C, Zucker JD, Langin D 2004 In vivo epinephrine-mediated regulation of gene expression in human skeletal muscle. J Clin Endocrinol Metab 89:2000-2014
2. Navegantes LC, Migliorini RH, do Carmo Kettelhut I 2002 Adrenergic control of protein metabolism in skeletal muscle. Curr Opin Clin Nutr Metab Care 5:281-286 (Pubitemid 40684673)
3. Lynch GS, Ryall JG 2008 Role of β-adrenoceptor signaling in skeletal muscle: implication for muscle wasting and disease. Physiol Rev 88:729-767
4. Navegantes LC, Resano NM, Migliorini RH, Kettelhut IC 2000 Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle. Am J Physiol Endocrinol Metab 279:E663-E668
5. Navegantes LC, ResanoNM,BavieraAM,MiglioriniRH,Kettelhut IC 2004 Effect of sympathetic denervation on the rate of protein synthesis in rat skeletal muscle. Am J Physiol Endocrinol Metab 286:E642-E647
6. Hinkle RT, Dolan E, Cody DB, Bauer MB, Isfort RJ 2005 Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy. Muscle Nerve 32:775-781 (Pubitemid 41746266)
7. Combaret L, Rallière C, Taillandier D, Tanaka K, Attaix D 1999 Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscle from tumor-bearing rats. Mol Biol Rep 26:95-101 (Pubitemid 29223258)
8. Lira EC, Graca FA, Goncalves DA, Zanon NM, Baviera AM, Strindberg L, Lönnroth P, Migliorini RH, Kettelhut IC, Navegantes LC 2007 Cyclic adenosine monophosphate-phosphodiesterase inhibitors reduce skeletal muscle protein catabolism in septic rats. Shock 27:687-694 (Pubitemid 46788169)
9. 2+-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats. Am J Physiol Endocrinol Metab 292:E702-E708
10. Lecker SH, Goldberg AL, Mitch WE 2006 Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol 17:1807-1819 (Pubitemid 44036165)
11. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, Glass DJ 2001 Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704-1708 (Pubitemid 33104839)
12. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL 2001 Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA 98:14440-14445 (Pubitemid 33121410)
13. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL 2004 Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412 (Pubitemid 38534545)
14. Kline WO, Panaro FJ, Yang H, Bodine SC 2007 Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. J Appl Physiol 102:740-747 (Pubitemid 46220906)
15. Pilegaard H, Saltin B, Neufer PD 2003 Exercise induces transient transcriptional activation of the PGC-1α gene in skeletal muscle. J Physiol 546:851-858 (Pubitemid 36204518)
16. Miura S, Kawanaka K, Kai Y, Tamura M, Goto M, Schiuchi T, Minokoshi Y, Ezaki O 2007 An increase in murine skeletal muscle peroxisome proliferators-activated receptor-γ coactivator-1α (PGC-1α) mRNA in response to exercise is mediated byβ-adrenergic receptor activation. Endocrinology 146:3441-3448 (Pubitemid 46997005)
17. Gibala MJ, McGee SL, Garnham AP, Howlett KF, Snow RJ, Hargreaves M 2009 Brief intense interval exercise activates AMPK and p38MAPKsignaling and increases the expression of PGC-1α in human skeletal muscle. J Appl Physiol 106:929-934
18. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM 1999 Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115-124 (Pubitemid 29331201)
19. Sandri M, Lin J, Handschi C, Yang W, Arany ZP, Lecker SH, Goldberg AL, Spiegelman BM 2006 PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy specific gene transcription. Proc Natl Acad Sci USA 103:16260-16265 (Pubitemid 44715184)
20. 2-adrenoceptors and cAMP. Am J Physiol Endocrinol Metab 281:E449-E454
21. Waalkes TP, Udenfriend S 1957 A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Invest 50: 733-736
22. Okuno Y, Huettner CS, Radomska HS, Petkova V, Iwasaki H, Akashi K, Tenen DG 2002 Distal elements are critical for human CD34 expression in vivo. Blood 100:4420-4426 (Pubitemid 35429680)
23. Yang H, Menconi MJ, Wei W, Petkova V, Hasselgren PO 2005 Dexamethasone upregulates the expression of the nuclear cofactor p300 and its interaction with C/EBPβ in cultured myotubes. J Cell Biochem 94:1058-1067 (Pubitemid 41420264)
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
25. Bdolah Y, Segal A, Tanksale P, Karumanchi SA, Lecker SH 2007 Atrophy-related ubiquitin ligases atrogin-1 and MuRF-1 are associated with uterine smooth muscle involution in the postpartum period. Am J Physiol Regul Integr Comp Physiol 292:R971-R976 (Pubitemid 46207754)
26. Bloom TJ 2002 Cyclic nucleotide phosphodiesterase isozymes expressed in mouse skeletal muscle. Can J Physiol Pharmacol 80:1132-1135 (Pubitemid 36249893)
27. Vary T, Dardevet D, Grizard J, Voisin L, Buffiere C, Denis P, Breuille D, Obled C 1999 Pentoxifylline improves insulin action limiting skeletal muscle catabolism after infection. J Endocrinol 163: 15-24 (Pubitemid 29481298)
28. Yimlamai T, Dodd SL, Borst SE, Park S 2005 Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin- proteasome pathway. J Appl Physiol 99:71-80 (Pubitemid 40934466)
29. 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. J Clin Invest 95:2367-2372
30. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL2004 IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287:E591-E601
31. De Rooji J, Rehmann H, van Triest M, Cool RH, Wittinghofer A, Bos JL 2000 Mechanisms of regulation of the Epac family of cAMP-dependent Rap GEFs. J Biol Biochem 275:20829-20836 (Pubitemid 30457676)
32. Mei FC, Oiao J, Tsygankova OM, Meinkoth JL, Quilliam LA, Cheng X 2002 Differential signaling of cyclic AMP:opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J Biol Chem 29:11497-11504 (Pubitemid 34952919)
33. Brennesvik EO, Ktori C, Ruzzin J, Jebens E, Shepherd PR, Jensen J 2005 Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for crosstalk between insulin and adrenaline. Cell Signal 17:1551-1559 (Pubitemid 41253994)
34. Bacurau AV, Jardim MA, Ferreira JC, Bechara LR, Bueno Jr CR, Alba-Loureiro TC, Negrao CE, Casarini DE, Curi R, Ramires PR, Moriscot AS, Brum PC 2009 Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training. J Appl Physiol 106:1631-1640
35. Nader GA 2005 Molecular determinants of skeletal muscle mass: getting the "AKT" together. Int J Biochem Cell Biol 37:1985-1996
36. Frost RA, Lang CH 2007 Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol 103:378-387
37. Meirhaeghe A, Crowley V, Lenaghan C, Lelliott C, Green K, Stewart A, Hart K, Schinner S, Sethi JK, Yeo G, Brand MD, Cortright RN, O'Rahilly S, Montague C, Vidal-Puig AJ 2003 Characterization of the human, mouse and rat PGC1β (peroxisome-proliferator-activated receptor-γ co-activator 1β) gene in vitro and in vivo. Biochem J 373:155-165